How have VIRS shares performed in 2024?

Pacer BioThreat Strategy ETF's stock was trading at $32.3154 at the beginning of 2024. Since then, VIRS shares have increased by 5.0% and is now trading at $33.9262. View the best growth stocks for 2024 here .

How often does Pacer BioThreat Strategy ETF pay dividends? What is the dividend yield for Pacer BioThreat Strategy ETF?

Pacer BioThreat Strategy ETF declared a dividend on Wednesday, September 20th. Shareholders of record on Friday, September 22nd will be given a dividend of $0.0785 per share on Wednesday, September 27th. The ex-dividend date is Thursday, September 21st. Read our dividend analysis for VIRS .

What does VIRS invest in?

Pacer BioThreat Strategy ETF is a equity fund issued by Pacer Financial. VIRS focuses on theme investments and follows the LifeSci BioThreat Strategy Index. The fund's investments total to approximately $3.39 million assets under management.

What stocks does Pacer BioThreat Strategy ETF hold?

VIRS invests in 54 holdings. Some of the stocks in their portfolio include NVIDIA (NVDA) , Netflix (NFLX) , Amazon.com (AMZN) , Merck & Co., Inc. (MRK) , Walmart (WMT) , Thermo Fisher Scientific (TMO) , Danaher (DHR) , Lowe's Companies (LOW) , Abbott Laboratories (ABT) and Home Depot (HD) .

What is the management fee for Pacer BioThreat Strategy ETF?

Pacer BioThreat Strategy ETF's management fee is 0.70% and has no other recorded expenses or fee waivers. The net expense ratio for VIRS is 0.70%.

Who are Pacer BioThreat Strategy ETF's major shareholders?

Pacer BioThreat Strategy ETF's stock is owned by many different institutional and retail investors. Top institutional shareholders include International Assets Investment Management LLC (14.36%).

How do I buy shares of Pacer BioThreat Strategy ETF?

Shares of VIRS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

BATS:VIRS

Pacer BioThreat Strategy ETF (VIRS) Price, Holdings, & News

→ SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad)

Free VIRS Stock Alerts

$33.67

-0.25 (-0.74%)

(As of 04/19/2024 ET)

Compare

Today's Range: $33.67
▼
$33.67
50-Day Range: $33.71
▼
$36.20
52-Week Range: N/A

Volume: 201 shs
Average Volume: N/A
Market Capitalization: $3.37 million

Assets Under Management: $3.39 million
Dividend Yield: 0.93%
Net Expense Ratio: 0.70%

Stock Analysis Chart Dividend Holdings Ownership Ratings

Get Pacer BioThreat Strategy ETF alerts:

About Pacer BioThreat Strategy ETF

The Pacer BioThreat Strategy ETF (VIRS) is an exchange-traded fund that is based on the LifeSci BioThreat Strategy index. The fund tracks a market-cap weighted index of US companies whose products or services address biological threats to human health. VIRS was launched on Jun 24, 2020 and is managed by Pacer.

VIRS Stock Price History

30 days | 90 days | 365 days | Advanced Chart

VIRS ETF News Headlines

No headlines for this company have been tracked by MarketBeat.com

Receive VIRS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pacer BioThreat Strategy ETF and its competitors with MarketBeat's FREE daily newsletter.

Fund Details

Issuer: Pacer Financial
Fund Name: Pacer BioThreat Strategy ETF
Tax Classification: Regulated Investment Company
Stock Exchange: BATS
Current Symbol: BATS:VIRS
Inception Date: 6/24/2020
Fund Manager: Bruce Kavanaugh, Michael Mack
Web: N/A
Phone: N/A

Fund Focus

Asset Class: Equity
Benchmark: LifeSci BioThreat Strategy Index
Category: Strategy
Focus: Theme
Development Level: Developed Markets
Region: North America
Number of Holdings: 54

Fund Statistics

Assets Under Management: $3.39 million
Average Daily Volume: $0.00
Discount/Premium: -0.01%

Administrator, Advisor and Custodian

Administrator: U.S. Bancorp Fund Services, LLC
Advisor: Pacer Advisors, Inc.
Custodian: U.S. Bank, N.A.
Distributor: Pacer Financial, Inc.
Transfer Agent: U.S. Bank, N.A.
Trustee: N/A
Lead Market Maker: RBC Capital Markets

Miscellaneous

Outstanding Shares: 100,000
Beta: 0.84
Creation Unit: 50,000
Creation Fee: $250.00

12 Stocks Corporate Insiders are Abandoning

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Ad Altimetry

Secret Bull Market Starts in This Unusual Sector

"We're only at the very beginning of a new wave that could deliver 500%-plus gains in the years to come." In fact, 50 small companies related to this sector have already soared 100% or more in a recent 90-day stretch.

Click for my No. 1 investment, all free of charge, click here.

Pacer BioThreat Strategy ETF Expenses

Type	VIRS	Theme ETFs	Equity ETFs	BATS ETFs	All ETFs
Management Fee	0.70%	0.57%	0.54%	0.56%	0.51%
Other Expenses	0.00%	0.72%	0.54%	0.51%	0.58%
Total Expense	0.70%	0.72%	0.70%	0.68%	0.70%
Fee Waiver	0.00%	-0.76%	-0.55%	-0.34%	-0.57%
Net Expense	0.70%	0.59%	0.60%	0.63%	0.58%

Pacer BioThreat Strategy ETF (VIRS) Holdings & Exposure

Top 10 VIRS Holdings

VIRS Sector Exposure

VIRS Industry Exposure

Full Holdings Details

Similar ETFs

Institutional Ownership

View All Institutional Transactions

VIRS ETF - Frequently Asked Questions

How have VIRS shares performed in 2024?: Pacer BioThreat Strategy ETF's stock was trading at $32.3154 at the beginning of 2024. Since then, VIRS shares have increased by 5.0% and is now trading at $33.9262.
View the best growth stocks for 2024 here.
How often does Pacer BioThreat Strategy ETF pay dividends? What is the dividend yield for Pacer BioThreat Strategy ETF?: Pacer BioThreat Strategy ETF declared a dividend on Wednesday, September 20th. Shareholders of record on Friday, September 22nd will be given a dividend of $0.0785 per share on Wednesday, September 27th. The ex-dividend date is Thursday, September 21st.
Read our dividend analysis for VIRS.
What does VIRS invest in?: Pacer BioThreat Strategy ETF is a equity fund issued by Pacer Financial. VIRS focuses on theme investments and follows the LifeSci BioThreat Strategy Index. The fund's investments total to approximately $3.39 million assets under management.
What stocks does Pacer BioThreat Strategy ETF hold?: VIRS invests in 54 holdings. Some of the stocks in their portfolio include NVIDIA (NVDA), Netflix (NFLX), Amazon.com (AMZN), Merck & Co., Inc. (MRK), Walmart (WMT), Thermo Fisher Scientific (TMO), Danaher (DHR), Lowe's Companies (LOW), Abbott Laboratories (ABT) and Home Depot (HD).

What is the management fee for Pacer BioThreat Strategy ETF?: Pacer BioThreat Strategy ETF's management fee is 0.70% and has no other recorded expenses or fee waivers. The net expense ratio for VIRS is 0.70%.
Who are Pacer BioThreat Strategy ETF's major shareholders?: Pacer BioThreat Strategy ETF's stock is owned by many different institutional and retail investors. Top institutional shareholders include International Assets Investment Management LLC (14.36%).
How do I buy shares of Pacer BioThreat Strategy ETF?: Shares of VIRS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (BATS:VIRS) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial